Divergence between human and murine peroxisome proliferator-activated receptor alpha ligand specificities

Journal of Lipid Research

Volumn 54, Issue 9, 2013, Pages 2354-2365

  Oswal, Dhawal P ^a   Balanarasimha, Madhumitha ^a   Loyer, Jeannette K ^a   Bedi, Shimpi ^a   Soman, Frances L ^a   Rider Jr , S Dean ^a   Hostetler, Heather A ^a  

^a WRIGHT STATE UNIVERSITY   (United States)

Author keywords

Endogenous ligand; Fatty acid; Long chain fatty acyl CoA; PPAR; Species differences; Transcription factor

Indexed keywords

LIGAND; LONG CHAIN FATTY ACID; LONG CHAIN FATTY ACYL COENZYME A; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CELL STRAIN COS7; HUMAN; LIGAND BINDING; MOUSE; NONHUMAN; PLASMID; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PURIFICATION; PROTEIN SECONDARY STRUCTURE; RECEPTOR BINDING; SPECIES DIFFERENCE;

ENDOGENOUS LIGAND; FATTY ACID; LONG CHAIN FATTY ACYL-COA; PPAR; SPECIES DIFFERENCES; TRANSCRIPTION FACTOR;

AMINO ACIDS, AROMATIC; ANIMALS; BORON COMPOUNDS; CERCOPITHECUS AETHIOPS; COS CELLS; ESTERS; FATTY ACIDS; HUMANS; LIGANDS; MICE; PPAR ALPHA; PROTEIN MULTIMERIZATION; PROTEIN STRUCTURE, QUATERNARY; PROTEIN STRUCTURE, SECONDARY; RETINOID X RECEPTOR ALPHA; SPECIES SPECIFICITY; SUBSTRATE SPECIFICITY; TRANSCRIPTIONAL ACTIVATION;

EID: 84883177811     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M035436     Document Type: Article

References (36)

1. Kliewer, S. A., K. Umesono, D. J. Noon, R. A. Heyman, and R. M. Evans. 1992. Convergence of 9-cis-retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors. Nature. 358: 771-774.
2. Gottlicher, M., E. Widmark, Q. Li, and J. A. Gustafsson. 1992. Fatty acids activate a chimera of the clofibric acid-activated receptor and the glucocorticoid receptor. Proc. Natl. Acad. Sci. USA. 89: 4653-4657.
3. Reddy, J. K., and T. Hashimoto. 2001. Peroxisomal beta-oxidation and peroxisome proliferator-activated receptor alpha: an adaptive metabolic system. Annu. Rev. Nutr. 21: 193-230.
4. Mangelsdorf, D. J., and R. M. Evans. 1995. The RXR heterodimers and orphan receptors. Cell. 83: 841-850.
5. Desvergne, B., L. Michalik, and W. Wahli. 2004. Be fit or be sick: peroxisome proliferator-activated receptors are down the road. Mol. Endocrinol. 18: 1321-1332.
6. Frederiksen, K. S., E. M. Wulf, K. Wassermann, P. Sauerberg, and J. Fleckner. 2003. Identification of hepatic transcriptional changes in insulin-resistant rats treated with peroxisome proliferator activated receptor-alpha agonists. J. Mol. Endocrinol. 30: 317-329.
7. Dreyer, C., G. Krey, H. Keller, F. Givel, G. Helftenbein, and W. Wahli. 1992. Control of the peroxisomal beta-oxidation pathway by a novel family of nuclear hormone receptors. Cell. 68: 879-887.
8. Maloney, E. K., and D. J. Waxman. 1999. Trans-activation of PPARalpha and PPARgamma by structurally diverse environmnetal chemicals. Toxicol. Appl. Pharmacol. 161: 209-218.
9. Bility, M. T., J. T. Thompson, R. H. McKee, R. M. David, J. H. Butala, J. P. Vanden Heuvel, and J. M. Peters. 2004. Activation of mouse and human peroxisome proliferator-activated receptors (PPARs) by phthalate monoesters. Toxicol. Sci. 82: 170-182.
10. Ellinghaus, P., C. Wolfrum, G. Assmann, F. Spener, and U. Seedorf. 1999. Phytanic acid activates the peroxisome proliferator-activated receptor alpha (PPARalpha) in sterol carrier protein-2-/sterol carrier protein x-deficient mice. J. Biol. Chem. 274: 2766-2772.
11. Lin, Q., S. E. Ruuska, N. S. Shaw, D. Dong, and N. Noy. 1999. Ligand selectivity of the peroxisome proliferator-activated receptor a. Biochemistry. 38: 185-190.
12. Hostetler, H. A., A. D. Petrescu, A. B. Kier, and F. Schroeder. 2005. Peroxisome proliferator activated receptor alpha (PPARalpha) interacts with high affinity and is conformationally responsive to endogenous ligands. J. Biol. Chem. 280: 18667-18682.
13. Hostetler, H. A., A. B. Kier, and F. Schroeder. 2006. Very-long-chain and branched-chain fatty acyl CoAs are high affinity ligands for the peroxisome proliferator-activated receptor alpha (PPARalpha). Biochemistry. 45: 7669-7681.
14. Keller, H., P. R. Devchand, M. Perroud, and W. Wahli. 1997. PPAR alpha structure-function relationships derived from species-specific differences in responsiveness to hypolipidemic agents. Biol. Chem. 378: 651-655.
15. Rakhshandehroo, M., G. Hooiveld, M. Muller, and S. Kersten. 2009. Comparative analysis of gene regulation by the transcription factor PPARalpha between mouse and human. PLoS ONE. 4: e6796.
16. Gonzalez, F. J., and Y. M. Shah. 2008. PPAR -: mechanism of species differences and hepatocarcinogenesis of peroxisome proliferators. Toxicology. 246: 2-8.
17. Sher, T., H-F. Yi, O. W. McBride, and F. J. Gonzalez. 1993. cDNA cloning, chromosomal mapping, and functional characterization of the human peroxisome proliferator activated receptor. Biochemistry. 32: 5598-5604.
18. Hubbell, T., W. D. Behnke, J. K. Woodford, and F. Schroeder. 1994. Recombinant liver fatty acid binding protein interactions with fatty acyl-coenzyme A. Biochemistry. 33: 3327-3334.
19. Hostetler, H. A., H. Huang, A. B. Kier, and F. Schroeder. 2008. Glucose directly links to lipid metabolism through high-affinity interactionwith peroxisome proliferator activated receptor-alpha. J. Biol. Chem. 283: 2246-2254.
20. Sreerama, N., and R. Woody. 2000. Estimation of protein secondary structure from circular dichroism spectra: Comparison of CONTIN, SELCON, and DCSSTR methods with an expanded reference set. Anal. Biochem. 287: 252-260.
21. Kim, J. B., H. M. Wright, M. Wright, and B. M. Spiegelman. 1998. Add1/SREBP1 activates PPARgamma through the production of endogenous ligand. Proc. Natl. Acad. Sci. USA. 95: 4333-4337.
22. Spector, A. A. 1969. Influence of pH of the medium on free fatty acid utilization by isolated mammalian cells. J. Lipid Res. 10: 207-215.
23. Petrescu, A. D., H. Huang, R. Hertz, J. Bar-Tana, F. Schroeder, and A. B. Kier. 2005. Role of regulatory F-domain in hepatocyte nuclear factor-4alpha ligand specificity. J. Biol. Chem. 280: 16714-16727.
24. Berbaum, J., and R. K. Harrison. 2005. Comparison of full-length versus ligand binding domain constructs in cell-free and cell-based peroxisome proliferator-activated receptor alpha assays. Anal. Biochem. 339: 121-128.
25. Francis, G. A., E. Fayard, F. Picard, and J. Auwerx. 2003. Nuclear receptors and the control of metabolism. Annu. Rev. Physiol. 65: 261-311.
26. Escher, P., and W. Wahli. 2000. Peroxisome proliferator activated receptors: insights into multiple cellular functions. Mutat. Res. 448: 121-138.
27. Kersten, S., B. Desvergne, and W. Wahli. 2000. Roles of PPARs in health and disease. Nature. 405: 421-424.
28. Huang, H., O. Starodub, A. McIntosh, A. B. Kier, and F. Schroeder. 2002. Liver fatty acid binding protein targets fatty acids to the nucleus: real-time confocal and multiphoton fluorescence imaging in living cells. J. Biol. Chem. 277: 29139-29151.
29. Huang, H., O. Starodub, A. McIntosh, B. P. Atshaves, G. Woldegiorgis, A. B. Kier, and F. Schroeder. 2004. Liver fatty acid binding protein colocalizes with peroxisome proliferator receptor alpha and enhances ligand distribution to nuclei of living cells. Biochemistry. 43: 2484-2500.
30. Lee, S. S. T., T. Pineau, J. Drago, E. J. Lee, J. W. Owens, D. L. Kroetz, P. M. Fernandez-Salguero, H. Wesphal, and F. J. Gonzalez. 1995. Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotrophic effects of peroxisome proliferators. Mol. Cell. Biol. 15: 3012-3022.
31. Aoyama, T., J. M. Peters, N. Iritani, T. Nakajima, K. Furihata, T. Hashimoto, and F. J. Gonzalez. 1998. Altered constitutive expression of fatty acid metabolizing enzymes in mice lacking PPARalpha. J. Biol. Chem. 273: 5678-5684.
32. Hashimoto, T., T. Fujita, N. Usuda, W. Cook, C. Qi, J. M. Peters, F. J. Gonzalez, A. V. Yeldandi, M. S. Rao, and J. K. Reddy. 1999. Peroxisomal and mitochondrial fatty acid beta-oxidation in mice nullizygous for both PPARalpha and peroxisomal fatty acyl CoA oxidase. J. Biol. Chem. 274: 19228-19236.
33. Laudet, V. 1997. Evolution of the nuclear receptor superfamily: early diversification from an ancestral orphan receptor. J. Mol. Endocrinol. 19: 207-226.
34. Morimura, K., C. Cheung, J. M. Ward, J. K. Reddy, and F. J. Gonzalez. 2006. Differential susceptibility of mice humanized for peroxisome proliferator-activated receptor alpha to Wy-14, 643-induced liver tumorigenesis. Carcinogenesis. 27: 1074-1080.
35. Hsu, M-H., C. N. A. Palmer, K. J. Griffin, and E. F. Johnson. 1995. A single amino acid change in the mouse peroxisome proliferator activated receptor alters transcriptional response to peroxisome proliferators. Mol. Pharmacol. 48: 559-567.
36. Shao, D., S. M. Rangwala, S. T. Bailey, S. L. Krakow, M. J. Reginato, and M. A. Lazar. 1998. Interdomain communication regulating ligand binding by PPAR-gamma. Nature. 396: 377-380.